Everything you need to know about HIV — transmission, symptoms, prevention, and treatment — plus our expert top 5 picks for at-home HIV tests ranked by sensitivity and ease of use.
HIV (Human Immunodeficiency Virus) attacks the immune system, destroying CD4 cells that fight infection. Without treatment, it progresses to AIDS. Modern antiretroviral therapy can make HIV undetectable and untransmittable.
HIV (Human Immunodeficiency Virus) remains one of the most significant global health challenges. In the United States, approximately 1.2 million people are living with HIV — and an estimated 13% don't know their status. Early detection is critical: people diagnosed early and on antiretroviral therapy (ART) can achieve an undetectable viral load, meaning they cannot transmit the virus to others and can expect a near-normal life expectancy.
At-home HIV testing has dramatically reduced testing barriers — removing the need for clinic visits, eliminating stigma-related anxiety, and making testing accessible on your own schedule. The CDC recommends that everyone between 13 and 64 get tested for HIV at least once as part of routine care, with more frequent testing for higher-risk individuals.
If you think you were exposed to HIV in the last 72 hours: Go to an emergency room or urgent care immediately and ask for PEP (Post-Exposure Prophylaxis). PEP is a 28-day antiretroviral regimen that can prevent HIV infection if started within 72 hours. Home tests are not the right tool in this window.
| Generation | What It Detects | Detection Window | Sensitivity | Used In |
|---|---|---|---|---|
| 3rd Gen (Antibody only) | HIV-1 & HIV-2 antibodies | 23–90 days post-exposure | 92–99% | OraQuick (oral swab) |
| 4th Gen (Ag/Ab combo) ⭐ | Antibodies + p24 antigen | 18–45 days post-exposure | 99.9%+ | Lab-send tests, clinics |
| RNA / NAT (PCR) | HIV RNA (the virus itself) | 10–33 days post-exposure | Highest (clinical only) | Clinical labs only |
Key takeaway: For the most accurate result and earliest detection, a 4th generation lab-send test is always preferred over the OraQuick oral swab. The oral swab's 92% sensitivity means 1 in 12 true positives may be missed.
Approximately 40–90% of people infected with HIV develop flu-like symptoms within 2–4 weeks of infection — called acute retroviral syndrome (ARS) or primary HIV infection. These symptoms typically last 1–4 weeks and are often mistaken for influenza or mononucleosis.
Low-grade to high fever — often the first sign, typically 102–104°F
Profound exhaustion that doesn't improve with rest
Flat, reddish rash often covering the trunk — characteristic of acute HIV
Painful sores in the throat and mouth; swollen lymph nodes
Body aches throughout muscles and joints
Severe headaches and in some cases neurological symptoms
Important: Most people with HIV have no symptoms for years after the acute phase. The only way to know your HIV status is to get tested. Symptoms alone cannot diagnose or rule out HIV.
HIV is transmitted through anal, vaginal, and (less commonly) oral sex without condoms. Anal sex carries the highest per-act risk.
Injection drug use with shared equipment is the second most common transmission route.
HIV can be transmitted during pregnancy, childbirth, or breastfeeding. With ART, transmission risk is reduced to under 1%.
Very rare in developed countries with blood screening. Higher risk in settings without blood safety programs.
Healthcare workers exposed to HIV-positive blood via needlestick — risk is approximately 0.3% per exposure.
Hugging, kissing, sharing food/drink, toilet seats, mosquitoes, sweat, or tears. HIV does not survive long outside the body.
Correct and consistent condom use reduces HIV transmission risk by 90–95%. Most effective when combined with other prevention methods.
Daily oral PrEP (Truvada or Descovy) reduces HIV acquisition risk by 99% for sexually active high-risk individuals. Requires prescription and quarterly monitoring.
Cabotegravir injection every 2 months — approved in 2021 — shown superior to daily oral PrEP in trials. Ideal for adherence-challenged patients.
Know your status and your partners' status. Regular testing enables early treatment and prevents unknowing transmission.
Post-exposure prophylaxis started within 72 hours of exposure can prevent infection. Available at emergency rooms and urgent care centers.
People on antiretroviral therapy who achieve undetectable viral load cannot sexually transmit HIV (U=U: Undetectable = Untransmittable).
HIV is not curable but is highly treatable. Modern antiretroviral therapy (ART) suppresses viral replication to undetectable levels, preventing immune system damage and stopping transmission. People who start ART early and maintain adherence can expect a near-normal life expectancy.
| Drug Class | Key Examples | Mechanism | Notes |
|---|---|---|---|
| INSTI (Integrase Inhibitors) | Bictegravir, Dolutegravir, Raltegravir | Block integrase — prevents HIV DNA from integrating into host cell | First-line preferred; excellent tolerability and resistance barrier |
| NRTI (Nucleoside RTIs) | Tenofovir, Emtricitabine, Abacavir | Block reverse transcriptase — prevent viral RNA copying | Backbone of most regimens; TDF/FTC is the preferred backbone |
| NNRTI | Rilpivirine, Efavirenz, Doravirine | Non-competitive RTIs — different binding site | Used in 2-drug regimens; food requirements for some agents |
| PI (Protease Inhibitors) | Darunavir (boosted) | Block protease — prevent viral maturation | Used when resistance is a concern; GI side effects common |
| Long-Acting Injectables | Cabenuva (cabotegravir + rilpivirine) | Monthly or bimonthly injection — eliminates daily pill | New option for adherence-challenged patients |
#1 Pick: 4th Generation Lab-Send Test (Biophan / myLAB Box) · Score: 9.7/10 · 5 products tested
The CDC recommends: all adults 13–64 should test at least once as a baseline. For sexually active individuals with multiple partners, inconsistent condom use, or injection drug use: every 3–6 months. For individuals on PrEP: every 3 months (required for continued prescription). For anyone who believes they may have been exposed: test 18–45 days post-exposure with a 4th generation test, then again at 90 days for final confirmation.
The window period is the time between HIV exposure and when a test can reliably detect infection. For 4th generation (antigen/antibody) tests: 18–45 days. For 3rd generation antibody-only tests (like OraQuick): 23–90 days. A negative result during the window period does not mean you are HIV-negative — you must retest after the window closes. The 90-day mark is considered conclusive for 3rd generation tests.
A reactive (two-line) OraQuick result means you tested preliminary positive for HIV antibodies. It does NOT mean you have HIV — OraQuick is a screening test with a 0.02% false positive rate. All reactive OraQuick results must be confirmed with a clinical blood test before a diagnosis is made. Call the OraQuick support line (1-800-HIV-0440) immediately for guidance. Do not panic — a reactive result most commonly leads to confirmatory testing, and rare false positives do occur.
A negative result from a 4th generation lab-send test taken 45+ days after potential exposure is highly reliable (99.9%+ accuracy). A negative OraQuick result taken 90+ days after exposure is also reliable but at 92% sensitivity there is a small residual risk. If you had a potential exposure and tested negative within the window period, you should retest after the window closes. Never rely on a single test taken too soon after exposure.
PrEP (Pre-Exposure Prophylaxis) is a daily medication that reduces HIV acquisition risk by 99% in sexually active high-risk individuals. It's recommended for: people with an HIV-positive partner, those who don't consistently use condoms with partners of unknown status, people who inject drugs and share equipment. PrEP requires a prescription, quarterly HIV testing, and kidney function monitoring. Talk to your doctor or visit a sexual health clinic to discuss eligibility.
A positive HIV diagnosis is not the end — it is the beginning of managing HIV as a chronic condition. With modern antiretroviral therapy, people living with HIV can achieve an undetectable viral load (meaning they cannot transmit the virus to others) and expect a near-normal life expectancy. The key steps: confirm the result with clinical testing, connect with an HIV specialist or infectious disease physician, start antiretroviral therapy as soon as possible, and link to support services. Organizations like The Well Project, POZ, and local AIDS service organizations provide invaluable support.
Every Tuesday we send you the single most useful review we published that week. No spam, no affiliate pitches, no clickbait — just the work.